Michael Barbella, Managing Editor09.09.23
New beginnings and (hopefully) happy endings drove ODT website traffic this past week.
Both restor3d and Globus Medical closed the book on their respective acquisitions (Conformis and NuVasive Inc., respectively), while Zimmer Biomet Holdings Inc. began a new chapter of its existence by forming a strategic alliance with HippoFi, a healthcare technology firm. The two companies will work to introduce a synthetic bone growth biomaterial next year.
Exactech and Moximed, meanwhile, amassed pageviews with milestone first cases: Exactech began its clinical relationship with the TriVerse primary knee, designed to address the demands of active patients, and Moximed kicked off its relationship with the MISHA knee system, an implantable shock absorber for medial knee osteoarthritis patients.
Both restor3d and Globus Medical closed the book on their respective acquisitions (Conformis and NuVasive Inc., respectively), while Zimmer Biomet Holdings Inc. began a new chapter of its existence by forming a strategic alliance with HippoFi, a healthcare technology firm. The two companies will work to introduce a synthetic bone growth biomaterial next year.
Exactech and Moximed, meanwhile, amassed pageviews with milestone first cases: Exactech began its clinical relationship with the TriVerse primary knee, designed to address the demands of active patients, and Moximed kicked off its relationship with the MISHA knee system, an implantable shock absorber for medial knee osteoarthritis patients.